Shijiazhuang, Hebei, China Viroad Biotechnology appeared to be the Corporate Investor, which was created in 2012. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Shijiazhuang.
Among the most popular fund investment industries, there are Health Care, Medical Device. Among the various public portfolio startups of the fund, we may underline GILUPI Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are KfW, High-Tech Gru00fcnderfonds, BC Brandenburg Capital. In the next rounds fund is usually obtained by Brandenburg Kapital.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2016. The top activity for fund was in 2011.
| Fund Name | Location |
| Anicom | Japan, Tokyo |
| Banco Santander | Madrid, Madrid, Spain |
| Bonit Capital | Stockholm, Stockholm County, Sweden |
| Capital Impetus Group | Central, Central Region, Singapore |
| Coffee Stain Studios | Sweden, Vastra Gotaland, Västra Götaland County |
| Gestion AD | - |
| Kohlberg Kravis Roberts Japan | Chiyoda, Japan |
| Nanhai Zhiku | China, Guangdong, Tianjin |
| Suneight PS1 Investment | - |
| William Blair | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GILUPI | $4M | 13 Jan 2011 | Potsdam, Brandenburg, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GILUPI | $4M | 13 Jan 2011 | Potsdam, Brandenburg, Germany |
